Table 3.
CDH1 mutation positive | CDH1 mutation negative | p value | |||
---|---|---|---|---|---|
n | % | n | % | ||
Total | 17 | 18 | 77 | 82 | |
Gender | |||||
Male | 7 | 14 | 43 | 86 | |
Female | 10 | 23 | 34 | 77 | 0.296 |
Age at diagnosis (years) | |||||
< 45 | 14 | 67 | 7 | 33 | |
45–59 | 2 | 6 | 30 | 94 | |
60–74 | 1 | 3 | 29 | 97 | |
> 75 | 0 | 0 | 11 | 100 | < 0.001 |
Tumour subtype | |||||
Diffuse | 17 | 34 | 33 | 66 | |
Intestinal | 0 | 0 | 22 | 100 | |
Other | 0 | 0 | 9 | 100 | |
NOS | 0 | 0 | 13 | 100 | < 0.001 |
Tumour grade | |||||
Well differentiated | 0 | 0 | 4 | 100 | |
Moderately differentiated | 0 | 0 | 10 | 100 | |
Poorly differentiated | 3 | 6 | 44 | 94 | |
NOS | 14 | 42 | 19 | 58 | < 0.001 |
Tumour site | |||||
Proximal | 4 | 13 | 26 | 87 | |
Distal | 1 | 5 | 19 | 95 | |
Mixed | 0 | 0 | 4 | 100 | |
Oesophageal junction | 0 | 0 | 5 | 100 | |
NOS | 12 | 34 | 23 | 66 | 0.048 |
Extent | |||||
Local | 15 | 58 | 11 | 42 | |
Lymph node involvement | 0 | 0 | 20 | 100 | |
Regional spread | 0 | 0 | 7 | 100 | |
Metastatic spread | 2 | 15 | 11 | 85 | |
NOS | 0 | 0 | 28 | 100 | < 0.001 |
NOS not otherwise specified